nCounter® PanCancer Progression Panel

Perform multiplex gene expression analysis with 770 genes from each step in the cancer progression process including: angiogenesis, extracellular matrix remodeling (ECM), epithelial-to-mesenchymal transition (EMT) and metastasis.

  • Comprehensive gene expression analysis of cancer progression
  • Quantify gene expression of metastatic growth and suppressor genes
  • Rapidly and easily screen samples for biomarker discovery or drug mechanism of action to support your research
  • Customizable with up to 30 additional user-defined genes with Panel Plus option
  • 3D-enabled for multi-analyte analysis with Vantage 3D™ Assays

The following is a pictorial description of the processes and key genes included in the PanCancer Progression Panel

The processes and key genes included in the PanCancer Progression Panel

Feature

Specifications

Number of Targets

770 including 30 PanCancer reference genes

Input Material

25 ng–300 ng

Sample Type(s)

FFPE-derived RNA, total RNA, fragmented RNA, cell lysates

Species

Human

Single Cell/Low Input Material Protocol

Yes

Customizable

Yes

Time to Results

Approximately 24 hours

Data Analysis

nSolver™ Analysis software

Shipping and Storage Conditions

-80°C

Click here to view publications.

Product

Description

Catalog Number

NAV Number

Unit Size

nCounter® PanCancer Progression Panel (CodeSet Only)

Gene Expression CodeSet profiling (770 genes). 740 cancer-related human genes plus 30 internal reference controls. Master Kit reagents sold separately.

XT-CSO-PROG1-12

115000152

12 reactions

For Research Use Only. Not for use in diagnostic procedures.